The Association of the British Pharmaceutical Industry (ABPI) has urged scientists to develop better pre-clinical models to accelerate the development of new medicines. The ABPI, in collaboration with the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), has published a landmark review examining the UK's capabilities in developing human-relevant pre-clinical models […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!